Pulmonary Hypertension Awareness Month: Two European Studies Highlight the Urgency of Patients and Experts to Improve the Diagnosis and Treatment of Pulmonary Hypertension Associated With Interstitial Lung Disease

Contributed by: Business Wire

Logo

Tags

Research

Clinical Trials

Cardiology

Practice Management

Biotechnology

Managed Care

General Health

Pharmaceutical

Health

Science

Pulmonary Hypertension

More Like This

David Ferrando, Ferrer's Chief Marketing and Market Access Officer and Jorge Cuneo, Ferrer's Chief Medical Officer, at the IMPAHCT opening session.

Experts Set International and Multidisciplinary Collaboration As Priorities in Pulmonary Hypertension Management

Ferrer Obtains the Distribution Rights for Treprostinil Inhalation Solution Including the Potential Indications for Idiopathic Pulmonary Fibrosis (IPF) and Progressive Pulmonary Fibrosis (PPF)

PR Newswire associated0

Recor Medical Champions Global Action on World Hypertension Day: Early Intervention and Continued Innovation Crucial in Tackling This Silent Killer Impacting Billions Worldwide

Lilly and Leading Alzheimer's Disease Experts Call for Urgent Action to Close Diagnostic Gaps at Alzheimer Europe Conference

Pulnovo Medical Announces Joining PHA's (Pulmonary Hypertension Association) Corporate Committee

Daiichi Sankyo Shines a Light on Inequalities and Unmet Needs in Care as Part of Its Commitment to People With Cardiovascular Disease

Novotech Identifies Strategic Opportunities in Idiopathic Pulmonary Fibrosis Trials with Release of Global Market Insights

PR Newswire associated0

Pierre Fabre Laboratories, committed to combating rare pediatric diseases via innovative therapies